• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

New drug capsule delivers medicine for weeks after swallowing

November 17, 2016 By Sarah Faulkner

New drug capsule delivers medicine for weeks after swallowingResearchers from Massachusetts Institute of Technology, spurred by a challenge from Bill Gates, developed a star-shaped drug capsule that can gradually release medication and stay in the stomach for to 2 weeks after being swallowed. The study, published yesterday in Science Translational Medicine, described the team’s work using the capsule to deliver an anti-parasitic drug, invermectin, which could help fight malaria.

The pill has 6 arms that are folded inwards, protected inside a smooth capsule. Drugs are loaded into each arm, which is attached to a core by a linking mechanism that eventually breaks down.

Once the capsule is swallowed, stomach acid dissolves the outer layer and the arms can unfold. The unfolded star is big enough to resist the forces that normally push oral drugs out of the system, but small enough that it won’t cause a blockage.

“When the star opens up inside the stomach, it stays inside the stomach for the duration that you need,” researcher Tyler Grant told Reuters.

The team tested the device in pigs and found that the drug doses were released over 2 weeks, at which point the linking mechanism that join the arms of the star to the core dissolve and break off, enabling the pill to pass through the system. Using mathematical models, researchers analyzed the potential impact of a long-acting capsule with invermectin and found that if it were used along with antimalaria treatments in 70% of a population, malaria transmission would decrease at the same rate if 90% of the population were given antimalaria treatments.

Long-acting drug delivery systems already exist as injections or implants, but researchers have long struggled to find a way to make oral drugs long-acting. Injections and implants involve invasive procedures and aren’t always suitable for the patient. But until now, oral drugs have had to act quickly due to the harsh environment of the stomach.

“Until now, oral drugs would almost never last for more than a day,” MIT professor and researcher Robert Langer told the news outlet.”This really opens the door to ultra-long-lasting oral systems … There are a lot of exciting things this could someday enable.”

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS